ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 88 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $83,000 | -76.4% | 24,783 | -34.9% | 0.06% | -75.9% |
| Q1 2017 | $351,000 | +19.4% | 38,083 | 0.0% | 0.23% | +91.6% |
| Q4 2016 | $294,000 | -73.1% | 38,083 | -60.2% | 0.12% | -67.1% |
| Q3 2016 | $1,094,000 | -5.3% | 95,743 | +2.1% | 0.36% | 0.0% |
| Q2 2016 | $1,155,000 | – | 93,810 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,400,289 | $19,889,000 | 2.53% |
| ADAMS STREET PARTNERS LLC | 1,473,061 | $6,658,000 | 1.70% |
| Iguana Healthcare Management, LLC | 700,000 | $3,164,000 | 0.87% |
| Perceptive Advisors | 2,076,578 | $9,386,000 | 0.18% |
| Birchview Capital, LP | 28,689 | $130,000 | 0.07% |
| Cannell & Co. | 303,971 | $1,374,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 25,249 | $114,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $172,000 | 0.03% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 313,775 | $1,418,000 | 0.03% |
| Candriam S.C.A. | 370,000 | $1,672,000 | 0.03% |